Haleon was formed in 2019 by the merger of the consumer healthcare businesses of GSK and US rival Pfizer, but was spun out and floated in 2022.

Pfizer has offloaded a £2.43billion stake in consumer health spin-out Haleon, which said it would buy back £230million of the ...

Pfizer (NYSE:PFE) has reduced its ownership in the British consumer healthcare giant Haleon (NYSE:HLN) to 15% from 22.6% by ...

A Matlock youngster was presented with a prestigious award by Prince Harry this week in recognition of the exceptional care ...

A nurse from Cardiff who has been described as a "guardian angel" has been celebrated for the amazing work that she does at ...

FTSE 100 Live 01 October Mulberry rejects Frasers bid approachGreggs' sales jump, shares fallMarket activity slows - ...

Exegenesis Bio’s SMA therapy is now in Phase 2 trials, building on earlier Phase 1 and 2 studies that demonstrated promising ...

Pfizer will receive around 2.66 billion pounds ($3.56 billion) in aggregate from Haleon from an offering and a share buyback. Goldman Sachs International said Tuesday that the pharmaceutical company ...

CVS Health's stock remains significantly undervalued by most metrics, even if management are struggling to unlock value.

Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million ...

Haleon separately said on Monday it had agreed to make an off-market purchase of about 230 million pounds ($308.18 million) ...

Goldman Sachs, JP Morgan, Morgan Stanley and UBS are global coordinators on the trade, with Barclays, Bank of America, BNP ...